Literature DB >> 18932207

Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.

Con Yiannikas1, Steve Vucic2.   

Abstract

Chronic acquired demyelinating polyneuropathy (CADP) is a heterogeneous syndrome that may be classified into a number of subtypes. Somatosensory evoked potentials (SSEPs) assess proximal segments of sensory nerves, inadequately assessed by routine nerve conduction studies (NCSs). The aim of the present study was to determine the utility of SSEPs in diagnosing and classifying different CADP subtypes. Forty-seven patients with CADP were studied and classified in five groups based on conventional NCSs and SSEPs. Some patients in Group 1 were initially misdiagnosed as having either motor neuron disease or multifocal motor neuropathy due to normal sensory NCSs, but they exhibited abnormal tibial and median nerve SSEPs, as evidenced by marked prolongation or absence of peripheral potentials (N9-median nerve, and N20-tibial nerve). These were reclassified as having chronic inflammatory demyelinating neuropathy (CIDP). In CIDP patients (Group 2), SSEPs were abnormal, thereby confirming the presence of demyelination in the proximal peripheral nerves. Patients with distal acquired demyelinating neuropathy (DADS) (Group 3), as defined by conventional NCS, exhibited abnormal SSEPs when anti-MAG antibodies were present. Anti-MAG-negative DADS patients (Group 3) had normal SSEPs. In the pure sensory ataxic group (Group 4), SSEP studies disclosed poorly formed and delayed cortical potentials with absent lumbar (N20) potentials, thereby suggesting the presence of proximal demyelination. SSEPs were normal in the pure motor CIDP and multifocal motor neuropathy patients (MMN) (Group 5), thereby differentiating asymmetric forms of CIDP from MMN. These findings suggest that SSEPs may be an important complementary investigation to conventional NCSs in the diagnosis of CADP.

Entities:  

Mesh:

Year:  2008        PMID: 18932207     DOI: 10.1002/mus.21078

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  A case of acute polyneuropathy with nephrotic syndrome showing transient proximal sensory conduction defects.

Authors:  Jeeyoung Oh; Seung-Min Kim; Il Nam Sunwoo
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

2.  Single-trial detection for intraoperative somatosensory evoked potentials monitoring.

Authors:  L Hu; Z G Zhang; H T Liu; K D K Luk; Y Hu
Journal:  Cogn Neurodyn       Date:  2015-07-23       Impact factor: 5.082

Review 3.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

4.  Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.

Authors:  Angelo Maurizio Clerici; Eduardo Nobile-Orazio; Marco Mauri; Federico Sergio Squellati; Giorgio Giovanni Bono
Journal:  BMC Neurol       Date:  2017-07-01       Impact factor: 2.474

5.  Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials.

Authors:  Marilisa Boscarino; Jacopo Lanzone; Lorenzo Ricci; Mario Tombini; Vincenzo Di Lazzaro; Giovanni Assenza
Journal:  Brain Sci       Date:  2020-05-08

6.  Optimizing Investigations for Evaluation of Enlargements of the Roots, Plexuses and Nerves: A Study of 133 Patients.

Authors:  Satish Khadilkar; Narayan Dilip Deshmukh; Neha H Shah; Sunila Jaggi; Khushnuma A Mansukhani; Bhagyadhan Patel; Sonali Shah; Sarika Patil; Vanaja Shetty
Journal:  Ann Indian Acad Neurol       Date:  2019-12-06       Impact factor: 1.383

7.  Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Filip Eftimov; Ilse M Lucke; Luis A Querol; Yusuf A Rajabally; Camiel Verhamme
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.